170877 ⎘
Detection or diagnosis of diseases; Genitourinary disorders Renal failures; Glomerular diseases; Tubulointerstitial diseases, e.g. nephritic syndrome, glomerulonephritis; Renovascular diseases, e.g. renal artery occlusion, nephropathy
METHODS FOR PREVENTING OR TREATING DISORDERS BY INCREASING BIOAVAILABILITY OF IRON AND RELATED PHARMACEUTICAL FORMULATION
#302Method for the early detection of acute kidney injury in critical patients, using fibroblast growth factor 23, klotho and erythropoietin as biomarkers
#303DIAGNOSTIC ASSAYS FOR SUPAR-β3 INTEGRIN DRIVEN KIDNEY DISEASES
#304METHOD TO DETECT BLOOD CREATININE AND AN IMMUNOSUPPRESSIVE DRUG
#305Treating hyperammonemia, reducing plasma ammonia with TLR4 antagonists
#306METHODS FOR EVALUATING RENAL INJURY AND RENAL FAILURE USING URINE LEVELS OF CHITINASE-3-LIKE PROTEIN 1
#307Disease-state biomarker for renal disease
#308METHOD AND KIT FOR DIAGNOSING EPITHELIAL-TO-MESENCHYMAL TRANSITION (EMT) OF THE PERITONEUM
#309IGFBP7 for prediction of risk of AKI when measured prior to surgery
#310Method for examining renal disease
#311Compositions and methods for detecting and/or treating inflammation
#312MODEL FOR ASSESSMENT OF KIDNEY FUNCTION IN CATS AND EVALUATION OF RELATED TREATMENT PROTOCOLS
#313TEST FOR MONITORING RENAL DISEASE
#314Methods and compositions for diagnosis and prognosis of renal injury and renal failure
#315Prognosis and monitoring of membranous nephropathy based on the analysis of PLA2R1 epitope profile and spreading
#316Follistatin-related protein 3 for diagnosis and prognosis of renal injury and renal failure
#317METHOD AND DEVICE FOR TESTING RENAL FUNCTION USING URINARY VEGF-A165b AS INDICATOR, AND PROGRAM AND RECORDING MEDIUM FOR CAUSING TO FUNCTION AS DEVICE FOR TESTING RENAL FUNCTION
#318KIDNEY FUNCTION BIOMARKERS
#319Diagnosis and treatment of MERS-related renal disease
#320METHOD FOR SCREENING DIABETIC NEPHROPATHY IN A SUBJECT
#321Specific Detection of Clusterin Isoforms
#322Method for predicting the risk of incidence of chronic kidney disease
#323TRANSCUTANEOUS ORGAN FUNCTION MEASUREMENT
#324METHODS FOR DETECTING RENAL DISEASE
#325Method for estimating number of podocytes in urine
#326PROTEIN BIOMARKERS AND THERAPEUTIC TARGETS FOR RENAL DISORDERS
#327DIAGNOSIS AND MONITORING OF CHRONIC RENAL DISEASE USING NGAL
#328Methods and compositions for diagnosis and prognosis of renal injury and renal failure
#329METHOD OF DIGITIZING NUTRITIONAL STATUS, MUSCLE TURNOVER, AND RISK ASSESSMENT
#330INHIBITION OF AXL/GAS6 SIGNALING IN THE TREATMENT OF LIVER FIBROSIS
#331Method and apparatus for determining a patient's filtration rate
#332Targeting cGMP-related phosphodiesterases to reduce cyst formation in cystic kidney disease, and related materials and methods
#333Methods and compositions for diagnosis and prognosis of renal injury and renal failure
#334METHODS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE
#335Assays for IGFBP7 having improved performance in biological samples
#336Metal tricarbonyl complexes comprising substituted iminodiactic acid ligands and uses as radioisotope tracers
#337Methods for determining the level of hyposialylation of Angptl4
#338Monitoring of neuromodulation using biomarkers
#339THERMOELECTRIC SENSOR FOR ANALYTES IN A GAS AND RELATED METHOD
#340Biomarkers related to kidney function and methods involving their use
#341Methods of diagnosing and predicting renal disease
#342Metabolite Biomarkers Predictive Of Renal Disease In Diabetic Patients
#343Early marker of proteinuria in patients treated with an anti-VEGF treatment
#344Nanoparticle probes and methods of making and use thereof
#345Methods and Devices for Detecting Diabetic Nephropathy and Associated Disorders
#346METHODS AND COMPOSITIONS FOR INHIBITING POLYOMAVIRUS-ASSOCIATED PATHOLOGY
#347Methods and compositions for diagnosis and prognosis of renal injury and renal failure
#348Animal model for non alcoholic steato hepatitis and liver fibrosis
#349DIAGNOSING AND TREATING IGA NEPHROPATHY
#350Methods for assessing efficacy of renal neuromodulation and associated systems and devices
#351Acute kidney injury detection system and methods
#352Methods and compositions for diagnosis and prognosis of renal injury and renal failure
#353Methods for the prevention and the treatment of extracapillary glomerulonephritis
#354ANIMAL MODEL FOR NEPHROPATHY AND AGENTS FOR TREATING THE SAME
#355METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE
#356BIOMARKERS OF FAST PROGRESSION OF CHRONIC KIDNEY DISEASE
#357Use of 1,25-dihydroxyvitamin D values in ratio with PTH as a prognostic biomarker
#358METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE
#359URINARY BIOMARKERS FOR SLE AND LUPUS NEPHRITIS
#360Methods and compositions for diagnosis and prognosis of renal injury and renal failure
#361Method for identifying an agent for treating abnormal kidney function
#362Use of charge-balanced imaging agents for determining renal function
#363RAC1 inhibitors for the treatment of Alport glomerular disease
#364PRECISE ESTIMATION OF GLOMERULAR FILTRATION RATE FROM MULTIPLE BIOMARKERS
#365ATYPICAL HEMOLYTIC UREMIC SYNDROME (AHUS) BIOMARKER PROTEINS
#366Methods and compositions for the detection and diagnosis of renal disease and periodontal disease
#367Nanoparticle probes and methods of making and use thereof
#368Method for diagnosing or monitoring kidney function or diagnosing kidney dysfunction
#369METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE
#370NT-pro ANP and SFlt-1 For The Differentiation Between Circulatory And Ischemic Events
#371METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE
#372METHODS FOR EVALUATING RENAL INJURY AND RENAL FAILURE USING URINE LEVELS OF CHITINASE-3-LIKE PROTEIN 1
#373Methods and compositions for diagnosis and prognosis of renal injury and renal failure
#374Method and panel for determining acute kidney injury
#375Biomarkers of polycystic kidney disease and uses thereof
#376Antibodies with high affinity for alpha-Klotho
#377Methods and kits for monitoring membranous nephropathy
#378Urine sample testing apparatus and apparatus for processing measurement result of urine sample
#379Medicament and apparatus for treating chronic kidney disease
#380Biomarker sampling in the context of neuromodulation devices, systems, and methods
#381Urine Biomarkers for Prediction of Recovery After Acute Kidney Injury: Proteomics
#382Electrochemical methods and devices for amending urine samples for immunosensor detection
#383Diagnostic and therapeutic uses of gelsolin in renal failure
#384A chronic renal disease diagnostic kit
#385Preventive or therapeutic agent for kidney disease
#386Mammalian Dickkopf 3 (DKK3) as Urinary Marker for Chronic Kidney Diseases
#387Exosome-mediated diagnosis of hepatitis virus infections and diseases
#388Early prediction markers of diabetic nephropathy
#389Methods for diagnosing risk of renal allograft fibrosis and rejection
#390METHOD FOR TEST ON DIABETIC NEPHROPATHY
#391TEST METHOD ON RENAL DISEASES
#392Devices and associated methods for monitoring of neuromodulation using biomarkers
#393Circulating KIM-1 levels for detection of pathologies associated with injury to, or cancer of, the kidney
#394PREDICTING RAPID DECLINE IN RENAL FUNCTION IN DIABETES
#395Method for treating kidney disease with a SLIT2-binding extracellular domain of ROBO2
#396Transcutaneous organ function measurement
#397Portable instrument for in vitro detection and quantification of biomarkers
#398Methods for diagnosing and assessing risk of developing glomerulosclerosis
#399PREDICTION AND RECOGNITION OF ACUTE KIDNEY INJURY AFTER SURGERY
#400METHODS AND COMPOSITIONS FOR THE EVALUATION OF RENAL INJURY USING HYALURONIC ACID
#401Methods useful for vitamin D deficiency and related disorders
#402In vitro diagnostic and prognosis of major adverse events in patients undergoing coronary angiography
#403DIAGNOSIS OF CHRONIC KIDNEY DISEASE BY QUANTITATIVE ANALYSIS OF POST-TRANSLATIONAL MODIFICATIONS OF PLASMA PROTEINS
#404METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE
#405Atypical hemolytic uremic syndrome (aHUS) biomarker proteins
#406Prognosing mortality in patients with chronic kidney disease by detecting macrophage inhibitory cytokine-1 (MIC-1)
#407Electrochemical methods and devices for amending urine samples for immunosensor detection
#408Methods and compositions for diagnosis and prognosis of renal injury and renal failure
#409NEPHROPATHY BIOMARKER
#410BIOMARKERS FOR ASSESSING KIDNEY DISEASES
#411MARKERS OF ACUTE KIDNEY FAILURE
#412Exosome-mediated diagnosis of hepatitis virus infections and diseases
#413DETECTING PODOCYTE INJURY IN DIABETIC NEPHROPATHY AND GLOMERULONEPHRITIS
#414NGAL for Diagnosis of Renal Conditions
#415Porous semiconductor metal oxide complex nanofibers including nanoparticle catalyst functionalized by nano-catalyst included within metal-organic framework, gas sensor and member using the same, and method of manufacturing the same
#416Prediction of acute kidney injury from a post-surgical metabolic blood panel
#417METHOD OF DIAGNOSING RENAL DISORDERS
#418TRPC6 involved in glomerulonephritis
#419Methods for treating disorders that involve immunoglobulin A
#420Methods for Early Diagnosis of Kidney Disease
#421Uses of GLI1 in detecting tissue fibrosis
#422Methods for the prevention and the treatment of extracapillary glomerulonephritis
#423Biomarkers for risk assessment and treatment monitoring in heart failure patients guided by natriuretic peptides
#424METHOD FOR THE ISOLATION, PURIFICATION AND AMPLIFICATION OF RENAL PROGENITORS CD133+CD24+ FROM THE URINE OF PATIENTS SUFFERING FROM RENAL DISEASES
#425Biomarkers and methods for progression prediction for chronic kidney disease
#426METHODS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE USING TREFOIL FACTOR 3 FAILURE
#427Marker for early diagnosis of kidney failure
#428Methods and compositions for diagnosis and prognosis of renal injury and renal failure
#429Methods and Compositions for the Treatment of Proteinuric Diseases
#430Assays for IGFBP7 having improved performance in biological samples
#431Compositions and methods for detecting and/or treating inflammation
#432Methods and compositions for diagnosis and prognosis of renal injury and renal failure
#433Methods of modulating the sialylation of Angptl4
#434Assessing renal structural alterations and outcomes
#435L-FABP BASED DIAGNOSIS OF KIDNEY INJURY AFTER AN ACUTE EVENT OR AFTER A SURGICAL INTERVENTION
#436LTBP2 AS A BIOMARKER FOR RENAL DYSFUNCTION
#437Homogenous immunoassay with compensation for background signal
#438URINARY NEUROPILIN-1 (NRP-1) AS A PROGNOSTIC MARKER FOR NEPHRITIS AND LUPUS NEPHRITIS
#439Methods for predicting the progression and treating a chronic kidney disease in a patient
#440Methods and Devices for Detecting Kidney Damage
#441Method for preventing and treating renal disease
#442Kidney disease biomarker
#443Miox antibody and assay
#444Urine sample testing apparatus and apparatus for processing measurement result of urine sample
#445TEST PAPER FOR DETECTION OF DIABETIC NEPHROPATHY
#446Methods for detecting renal disease
#447METHODS FOR DIAGNOSING AND ASSESSING KIDNEY DISEASE
#448Non-Glycosylated suPar Biomarkers and Uses Thereof
#449Methods of Detecting Kidney-Associated Diseases or Conditions
#450METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE
#451METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE
#452P2X7 RECEPTOR AGONIST FOR USE IN PREVENTING OR TREATING KIDNEY INJURY
#453Biomarkers related to kidney function and methods using the same
#454Systems and methods for characterizing kidney diseases
#455GDF-15 and/or Troponin T for Predicting Kidney Failure in Heart Surgery Patients
#456METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE
#457Methods for Early Diagnosis of Kidney Disease
#458Compositions and methods for treating steroid resistant nephrotic syndrome and/or steroid sensitive nephrotic syndrome
#459Early marker of proteinuria in patients treated with an anti-VEGF treatment
#460Methods for Predicting Cardiovascular Mortality Risk
#461Methods and compositions for diagnosis and prognosis of renal injury and renal failure
#462Method for evaluating urine sample, analyzer, and analysis system
#463Mutations in DSTYK cause dominant urinary tract malformations
#464Use of SHROOM3 in chronic kidney disease and chronic allograft nephropathy
#465Method for measuring indoxyl sulfuric acid
#466Non-oxidized, biological active parathyroid hormone determines mortality in hemodialysis patients
#467METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE
#468Methods of Treating Acute Kidney Injury
#469METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE
#470METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE
#471METHOD FOR DETECTING PODOCYTES IN URINE
#472Method for estimating GFR (glomerular filtration rate) from measured value of megalin in urine
#473Podocyte cultures and uses thereof
#474PREDICTION OF KIDNEY DISEASE PROGRESSION USING HOMOARGININE AS A BIOMARKER
#475Method of assessing a subject for abnormal kidney function
#476Methods and compositions for diagnosis and prognosis of renal injury and renal failure
#477INDOXYL SULFATE MEASUREMENT METHOD
#478Signal biomarkers
#479Extracorporeal removal of anti-IQCJ antibodies from blood
#480AUTOSOMAL-DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD)
#481Urinary biomarkers for predicting long-term dialysis
#482Apparatus and apparatus control method for the quantitative concentration determination of selected substances filtered out of a patient's body in a fluid
#483Method to determine treatment of acute heart failure
#484ASSESSING RENAL STRUCTURAL ALTERATIONS AND OUTCOMES
#485Methods and compositions for diagnosis and prognosis of renal injury and renal failure
#486A RAPID QUANTITATIVE ASSAY TO MEASURE CFTR FUNCTION IN A PRIMARY INTESTINAL CULTURE MODEL
#487Method for testing for nephritis-lesion sites and reagent therefor
#488Method for diagnosing or monitoring kidney function or diagnosing kidney dysfunction
#489EVALUATING RENAL INJURY USING HYALURONIC ACID
#490Kidney disease biomarker
#491Compositions and methods for detecting, treating and preventing diseases and disorders
#492Predicting and treating diabetic complications
#493Biomarker of renal dysfunction
#494RAC1 inhibitors for the treatment of alport glomerular disease
#495METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE
#496Methods useful for vitamin D deficiency and related disorders
#497METHODS FOR DIAGNOSING AND TREATING FOCAL SEGMENTAL GLOMERULOSCLEROSIS
#498Determination of Neutrophil Gelatinase-Associated Lipocalin (NGAL) as a Diagnostic Marker for Renal Disorders
#499Method of selecting phosphate binder and its uses thereof
#500Biomarker of renal dysfunction
#501SGLT2 AS BIOMARKER FOR DIAGNOSING CHRONIC KIDNEY DISEASE AND MONITORING THE DISEASE STATUS AFTER TREATMENT
#502METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE
#503MECHANISM, DIAGNOSTIC, AND TREATMENTS FOR COMPLICATIONS OF RENAL FAILURE
#504Thermoelectric sensor for analytes in a gas and related method
#505URINARY BIOMARKERS OF RENAL AND MITOCHONDRIAL DYSFUNCTION
#506METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE
#507Methods for diagnosis and prognosis of renal injury and renal failure
#508METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE
#509ROBO2 inhibitory compositions comprising SLIT2-binding extracellular domain of ROBO2
#510METHOD FOR THE DETERMINATION OF RENAL FUNCTION
#511KIDNEY FUNCTION BIOMARKERS
#512Means and methods of measuring parathyroid hormone in patients suffering from oxidative stress
#513Peptides and Methods for Detecting MPO-ANCA
#514APOLIPOPROTEIN L-I VARIANTS AND THEIR USE
#515MEANS AND METHODS FOR ASSESSING KIDNEY TOXICITY
#516Rapid quantitative assay to measure CFTR function in a primary intestinal culture model
#517SYSTEMS AND METHODS FOR CHARACTERIZING LUPUS ERYTHEMATOSUS
#518METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE
#519DIAGNOSIS AND MONITORING OF CHRONIC RENAL DISEASE USING NGAL
#520Methods for diagnosis and prognosis of renal injury and renal failure using insulin-like growth factor-binding protein 7 and metalloproteinase inhibitor 2
#521METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE
#522Diagnosing and treating IGA nephropathy
#523Methods and compositions for monitoring and risk prediction in cardiorenal syndrome
#524Hepatic insulin sensitizing substance and test meal for insulin sensitization
#525METHOD FOR MONITORING, DIAGNOSIS AND/OR PROGNOSIS OF ACUTE KIDNEY INJURY IN EARLY STAGE
#526Urinary biomarkers for predicting long-term dialysis
#527Methods and compositions for diagnosis and prognosis of renal injury and renal failure
#528Methods for preventing or treating disorders by increasing bioavailability of iron and related pharmaceutical formulation
#529Electrochemical methods and devices for amending urine samples for immunosensor detection
#530Electrochemical methods and devices for amending urine samples for immunosensor detection
#531Method of assessing diabetic nephropathy using CD5 antigen-like
#532Diagnosis, prognosis, and treatment of kidney disease
#533Chymase compositions, antibodies, diagnostics, and therapeutic methods related thereto
#534Levels of BCMA protein expression on B cells and use in methods of treating systemic lupus erythematosus
#535Methods and compositions for diagnosis and prognosis of renal injury and renal failure
#536Predicting and treating diabetic complications
#537Use of an anti-CD200 antibody for prolonging the survival of allografts
#538Methods and compositions for inhibiting polyomavirus-associated pathology
#539Autoantibody biomarkers for IGA nephropathy
#540Exosome-mediated diagnosis of hepatitis virus infections and diseases
#541Method for the early detection of renal disease using proteomics
#542Methods and composition for measuring the amount of vitamin D derivatives
#543Methods and kits for predicting the risk of respiratory failure, renal failure or thrombopenia in a septic patient by measuring endocan levels in blood
#544Biomarkers for acute kidney injury
#545Compositions and methods for diagnosing and treating kidney disorders in a feline
#546Cell division marker
#547Compositions and methods for monitoring oxalate
#548Composition and method for the diagnosis and treatment of iron-related disorders
#549Treating renal and liver dysfunction with TLR4 antagonists
#550Animal model for diabetic complications
#551Urine biomarkers for prediction of recovery after acute kidney injury: proteomics
#552Early marker of proteinuria in patients treated with an anti-VEGF treatment
#553Monitoring of neuromodulation using biomarkers
#554Biomarkers associated with nephropathy
#555Method and compositions for the treatment and detection of endothelin-1 related kidney diseases
#556Method of detecting a urine protein fragment and a serum protein fragment
#557Method of identifying when a patient undergoing hemodialysis is at increased risk of death
#558Biomarker sampling in the context of neuromodulation devices, systems, and methods
#559Detection of chronic kidney disease and disease progression
#560Method for predicting a need for renal replacement therapy (RRT)
#561Methods and compositions for diagnosis and prognosis of renal injury and renal failure
#562Assays, methods and kits for predicting renal disease and personalized treatment strategies
#563Inhibition of AXL/GAS6 signaling in the treatment of liver fibrosis
#564Methods and compositions for diagnosis and prognosis of renal injury and renal failure
#565Diagnostic marker for kidney diseases and use thereof
#566METHOD AND KIT FOR DETECTING THE EARLY ONSET OF RENAL TUBULAR CELL INJURY
#567DIAGNOSIS AND MONITORING OF CHRONIC RENAL DISEASE USING NGAL
#568Markers for acute kidney injury
#569Markers for renal disease
#570Perlecan as a biomarker for renal dysfunction
#571Prediction and recognition of acute kidney injury after surgery
#572Methods for diagnosing and assessing risk of developing glomerulosclerosis
#573KIDNEY PROGNOSTIC ASSAY
#574DIAGNOSTIC METHOD FOR DETECTING ACUTE KIDNEY INJURY USING HEAT SHOCK PROTEIN 72 AS A SENSITIVE BIOMARKER
#575DIGANOSIS OF A RENAL DISEASE BY OXYGEN AND HYDROGEN ISOTOPES IN A BIOLOGICAL SAMPLE
#576METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE
#577Material for removing cauxin in cat urine
#578LTBP2 AS A BIOMARKER FOR RENAL DYSFUNCTION
#579DETECTION OF NGAL IN CHRONIC RENAL DISEASE
#580Chitinase-3-Like Protein 1 as a Biomarker of Recovery from Kidney Injury
#581EARLY MARKER OF PROTEINURIA IN PATIENTS TREATED WITH AN ANTI-VEGF TREATMENT
#582METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE
#583Cystatin C, β2 microglobulin, α1 microglobulin and genes for same, antibody, and kit and method for diagnosis of feline nephropathy
#584PROTEIN BIOMARKERS AND THERAPEUTIC TARGETS FOR RENAL DISORDERS
#585Method for examining acute renal disorder
#586METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE
#587Method of diagnosing renal dysfunction in a cat based on non-cauxin protein levels
#588Compositions and methods for diagnosing and treating kidney disorders in a canine
#589Methods for prognosis of future acute renal injury and acute renal failure
#590Biomarkers for the Diagnosis of Kidney Graft Rejection
#591DIAGNOSING AND TREATING IGA NEPHROPATHY
#592Method for evaluating renal status by determining beta-2-glycoprotein 1
#593METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE
#594GDF-15 and/or Troponin T for Predicting Kidney Failure in Heart Surgery Patients
#595PODOCYTE SPECIFIC ASSAYS AND USES THEREOF
#596Methods and compositions for diagnosis and prognosis of renal injury and renal failure
#597METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE
#598METHOD FOR THE DETECTION OF RENAL DAMAGE
#599NGAL FOR DIAGNOSIS OF RENAL CONDITIONS
#600NT-pro ANP and SFlt-1 for the differentiation between circulatory and ischemic events